General Information of the Compound
| Compound ID |
CP0541581
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
18073-34-2
5-23-09-00418 (Beilstein Handbook Reference)
6H-Pyrido(4,3-b)carbazole, 9-bromo-5,11-dimethyl-
6H-Pyrido[4, 9-bromo-5,11-dimethyl-
9-Bromo-5,11-dimethyl-6H-pyrido(4,3-b)carbazole
9-Bromo-5,11-dimethyl-6H-pyrido[4,3-b]carbazole
9-Bromoellipticine
AC1L3XSF
ACM18073342
BDBM50174409
BRN 0543507
CHEMBL194474
DTXSID80171005
Ellipticine, 9-bromo-
NSC 98927
NSC-98927
NSC98927
ZINC13284221
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C17H13BrN2
|
||||||||||||||||||
| Molecular Weight |
325.209
|
||||||||||||||||||
| Canonical SMILES |
Cc1c2[nH]c3ccc(Br)cc3c2c(C)c2cnccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C17H13BrN2/c1-9-14-8-19-6-5-12(14)10(2)17-16(9)13-7-11(18)3-4-15(13)20-17/h3-8,20H,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
OSDDZVXUCKZOQA-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
18073-34-2
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound